DRG Instruments GmbH of Marburg at MEDICA 2019 in Düsseldorf -- MEDICA - World Forum for Medicine
Manage stand orders
Select Option
Manufacturers Trader OEM

DRG Instruments GmbH

Frauenbergstr. 18, 35039 Marburg
Telephone +49 6421 1700-0
Fax +49 6421 1700-50

Hall map

MEDICA 2019 hall map (Hall 3): stand A69

Fairground map

MEDICA 2019 fairground map: Hall 3

Our range of products

Product categories

  • 02  Laboratory Technology
  • 02.01  Analyser systems / equipment

Analyser systems / equipment

  • 03  Diagnostic Tests
  • 03.02  Immunochemistry testing, immunology testing
  • 03.02.01  Immuno assay testing

Immuno assay testing

  • 03  Diagnostic Tests
  • 03.02  Immunochemistry testing, immunology testing
  • 03.02.04  Other equipment for immunochemistry and immunology

Other equipment for immunochemistry and immunology

  • 03  Diagnostic Tests
  • 03.05  Infectious immunology testing
  • 03.05.02  Microbiological diagnosis, virology, equipment and systems for

Microbiological diagnosis, virology, equipment and systems for

Our products

Product category: Microbiological diagnosis, virology, equipment and systems for


  • Fasciola
  • Rickettsia conorii IgM
  • Meningitis IgG
  • Chikungunya IgG/IgM
  • Clostridium difficile
  • Zika Virus IgM µ-capture
At the end of 2003 DRG has taken over the assets of NOVUM Diagnostika, Dietzenbach. NOVUM has developed and manufactured a wide range of products to identify and manage infectious diseases. Now DRG is manufacturing these ELISAS in the same excellent quality and offers these assays at competitive prices.

More Less

Product category: Immuno assay testing


  • Annexin V Ab ELISA
  • IP-10 (human) ELISA
  • Interleukin-21 ELISA
  • TNF Beta ELISA
C5a - A proteolytic product of the complement protein C5. C5a is an important proinflammatory mediator with both anaphylatoxic and chemotactic effects.Therefore, it is active in engendering both the vascular und cellular phases of the inflammatory response. This product was formerly manufactured by Dade Behring, now exclusive by DRG Instruments.

More Less

Product category: Analyser systems / equipment

E-LizaMat 8882

Fully automated 2 plate ELISA processor able to operate
the dispense, incubation, reading, data processing and storage of results.Benefits

Open System
  • 80 Samples
  • 8 Different Assays
  • 2 Microtiter Plates
  • Autodilution in one Session
E-LizaMat GS (ELM GS)
This 2-plate fully automated open platform is compact, efficient and innovative. Features include positive identification sample rachs, continous barcode reading and on-board optics for remote trouble-shooting access. The interface is bi-directional and compatible with any LIS system. User frindly, flexible, and customizable software make automation possible for any EIA application. Up to 192 results can be generated in one run on a combination of up to 8 assays.

More Less

About us

Company details

DRG, founded in 1970, is a multinational specialty medical equipment and diagnostics manufacturer and distributor, with successful representation in over 110 countries through a network of DRG Subsidiaries and local distributors.

The German division, DRG Instruments GmbH, founded in 1973, is located in Marburg and specializes in the development and production of innovative ELISAS and Chemiluminescent assays, both for routine and research applications, in the fields of diabetes diagnosis, endocrinology, prenatal/neonatal supervision, thyroid function and many more.

Recently, DRG developed the world’s first nonradioactive immunoassays for the determination of active Renin and PLGF as well as a complete panel of sensitive assays for the quantitative determination of saliva steroids. In the last five years, we have developed our own tumor marker panel and a broad range of ELISAs in the field of infectious diseases, including the world’s first assay for the qualitative detection of human Fasciola IgG.

The DRG serum steroid ELISAS like 17-OH Progesterone, DHEA, Testosterone and other bestsellers, have held a leading position in the field of gynecologic endocrinology worldwide for many years.
Our newest development is an ELISA for the determination of 25-OH Vitamin D Total, a sensitive assay, which correlates perfectly to established RIAs.

In addition to our in-house developed and manufactured assays, we offer a wide range of innovative assays, both ELISAs and RIAs, in OEM format, in the fields of autoimmunity, immunology, bone and mineral and many others.
At the end of 2008, DRG began development of a closed system, our DRG:HYBRiD-XL, a fully automated analyzer for the simultaneous determination of immunoassays, as well as clinical chemistry.

More Less